Unmet Needs and Future Perspectives in Newly Diagnosed and Relapsed/Refractory MM

Video

The panel shares some unmet needs in the multiple myeloma treatment landscape and exciting developments on the horizon.

Recent Videos
Marc S. Raab, MD, PhD, details how agents like carfilzomib may play a role in treatment after progression on teclistamab-based induction therapy.
The safety profile of teclistamab-based therapy in the MajesTEC-5 trial was expected based on the known compounds employed in each combination.
4 experts in this video
4 experts in this video
Related Content